The origin and application of experimental autoimmune encephalomyelitis

Experimental autoimmune encephalomyelitis (EAE) is a model of the neuroimmune system responding to priming with central nervous system (CNS)-restricted antigens. It is an excellent model of post-vaccinal encephalitis and a useful model of many aspects of multiple sclerosis. EAE has been established in numerous species and is induced by priming with a large number of CNS-derived antigens. As a consequence, the pathogenesis, pathology and clinical signs vary significantly between experimental protocols. As I describe in this Timeline article, the reductionist approach taken in some lines of investigation of EAE resulted in a reliance on results obtained under a narrow range of conditions. Although such studies made important contributions to our molecular understanding of inflammation, T-cell activation, and MHC restriction, they did not advance as effectively our knowledge of the polyantigenic responses that usually occur in CNS immunopathology and autoimmunity.

[1]  Garry P Nolan,et al.  Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling , 2006, Nature Methods.

[2]  Jeffrey A. Cohen,et al.  Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. , 1995, Neurology.

[3]  S. Nelson,et al.  A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis , 2000, Neurology.

[4]  J. Matthew Mauro,et al.  Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.

[5]  E. Kabat,et al.  THE PATHOLOGY OF ACUTE DISSEMINATED ENCEPHALOMYELITIS PRODUCED EXPERIMENTALLY IN THE RHESUS MONKEY AND ITS RESEMBLANCE TO HUMAN DEMYELINATING DISEASE , 1947, Journal of neuropathology and experimental neurology.

[6]  E. Einstein,et al.  THE ISOLATION FROM BOVINE SPINAL CORD OF A HOMOGENEOUS PROTEIN WITH ENCEPHALITOGENIC ACTIVITY * , 1962, Journal of neurochemistry.

[7]  P. Y. Paterson,et al.  ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING IMMUNIZATION WITH HOMOLOGOUS BRAIN EXTRACTS , 1950, The Journal of experimental medicine.

[8]  I. Cohen,et al.  The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.

[9]  E. Kabat,et al.  THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS , 1946, The Journal of experimental medicine.

[10]  R. Knobler,et al.  T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination , 1985, Nature.

[11]  A. Ben-nun,et al.  The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS) , 2000, Journal of Neuroimmunology.

[12]  H. Lassmann,et al.  Synergism in the Pathogenesis of EAE Induced by an MBP‐Specific T‐Cell Line and Monoclonal Antibodies to Galactocerebroside or a Myelin Oligodendroglial Glycoprotein a , 1988 .

[13]  E. Kabat,et al.  Rapid Production of Acute Disseminated Encephalomyelitis in Rhesus Monkeys by Injection of Brain Tissue With Adjuvants , 1946, Science.

[14]  R. Shapira,et al.  THE MAJOR SITE OF GUINEA‐PIG MYELIN BASIC PROTEIN ENCEPHALITOGENIC IN LEWIS RATS 1 2 , 1977, Journal of neurochemistry.

[15]  C. Pettinelli,et al.  Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. , 1982, Journal of immunology.

[16]  R. Fujinami,et al.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.

[17]  M. Kies PANEL DISCUSSION ON SPECIES VARIABILITY AND MULTIPLE ANTIGENS IN EAE: SUMMARY STATEMENT , 1965, Annals of the New York Academy of Sciences.

[18]  P. K. Olitsky,et al.  EXPERIMENTAL DISSEMINATED ENCEPHALOMYELITIS IN WHITE MICE , 1949, The Journal of experimental medicine.

[19]  G. Comi,et al.  Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. , 2003, Brain : a journal of neurology.

[20]  Subramaniam Sriram,et al.  Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis , 2005, Annals of neurology.

[21]  D. Loh,et al.  Murine T-cell receptor mutants with deletions of beta-chain variable region genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Laufer,et al.  An experimental demyelinative disease in the Syrian hamster. , 1958, British journal of experimental pathology.

[23]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[24]  D. McFarlin,et al.  Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. , 1983, Journal of immunology.

[25]  A. Baxter,et al.  On lawnmowers and lay‐down misères , 2004, Immunology.

[26]  A. Moser,et al.  Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. , 1987, The New England journal of medicine.

[27]  A. B. Robinson,et al.  Experimental Allergic Encephalomyelitis: Synthesis of Disease-Inducing Site of the Basic Protein , 1970, Science.

[28]  L. Roizin,et al.  PRODUCTION OF EXPERIMENTAL ENCEPHALOMYEUTIS WITH CALCIUM ACETATE COMPOUND EXTRACTED FROM BRAIN TISSUE† , 1951, Journal of neuropathology and clinical neurology.

[29]  T. Rivers,et al.  THE ANTIBODY RESPONSE OF RABBITS TO INJECTIONS OF EMULSIONS AND EXTRACTS OF HOMOLOGOUS BRAIN , 1934, The Journal of experimental medicine.

[30]  H. Mcdevitt,et al.  Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Alvord,et al.  THE ENCEPHALOMYELITIC ACTIVITY OF MYELIN ISOLATED BY ULTRACENTRIFUGATION , 1962, The Journal of experimental medicine.

[32]  S. Barnum,et al.  Attenuation of Experimental Autoimmune Demyelination in Complement-Deficient Mice1 , 2000, The Journal of Immunology.

[33]  D. McFarlin,et al.  Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins , 1977, The Journal of experimental medicine.

[34]  R. Grinker,et al.  HUMAN RABIES AND RABIES VACCINE ENCEPHALOMYELITIS: A CLINICOPATHOLOGIC STUDY , 1930 .

[35]  R. Adams,et al.  The morbid anatomy of the demyelinative diseases , 1952 .

[36]  P. Chattopadhyay,et al.  Seventeen-colour flow cytometry: unravelling the immune system , 2004, Nature Reviews Immunology.

[37]  P. Fitzgerald-Bocarsly,et al.  Receptor Cross-Linking on Human Plasmacytoid Dendritic Cells Leads to the Regulation of IFN-α Production1 , 2006, The Journal of Immunology.

[38]  I. Egorov,et al.  Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. , 1985, Journal of immunology.

[39]  T. Mak,et al.  Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice , 1992, Science.

[40]  G. Stuart,et al.  A FATAL NEURO-PARALYTIC ACCIDENT OF ANTIRABIES TREATMENT. , 1930 .

[41]  L. Morrison Disseminated encephalomyelitis experimentally produced by the use of homologous antigen. , 1947, Archives of neurology and psychiatry.

[42]  A. Verma Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab , 2006 .

[43]  S. Levine,et al.  Experimental allergic encephalomyelitis in inbred and outbred mice. , 1973, Journal of immunology.

[44]  R. Adams,et al.  A STUDY OF THE CHEMICAL NATURE OF COMPONENTS OF BOVINE WHITE MATTER EFFECTIVE IN PRODUCING ALLERGIC ENCEPHALOMYELITIS IN THE RABBIT , 1954, The Journal of experimental medicine.

[45]  B. Hall,et al.  Cutting Edge: FADD Is Not Required for Antigen Receptor-Mediated NF-κB Activation1 , 2005, The Journal of Immunology.

[46]  H. Weiner,et al.  A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.

[47]  R. C. Parker,et al.  Propagation of Rabies Virus in Tissue Culture.∗ , 1945, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[48]  E. Spack,et al.  Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. Waksman,et al.  THE USE OF SPECIFIC "LYMPHOCYTE" ANTISERA TO INHIBIT HYPERSENSITIVE REACTIONS OF THE "DELAYED" TYPE , 1961, The Journal of experimental medicine.

[50]  A. Ferraro PATHOLOGY OF DEMYELINATING DISEASES AS AN ALLERGIC REACTION OF THE BRAIN , 1944 .

[51]  Bernhard Ø Palsson,et al.  Automated in situ measurement of cell-specific antibody secretion and laser-mediated purification for rapid cloning of highly-secreting producers. , 2005, Biotechnology and bioengineering.

[52]  H. Lassmann,et al.  Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. , 2004, Brain : a journal of neurology.

[53]  Lawrence Steinman,et al.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy , 1989, Cell.

[54]  D. McFarlin,et al.  Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. , 1983, Journal of immunology.

[55]  G. Ward,et al.  Laser scanning cytometer‐based assays for measuring host cell attachment and invasion by the human pathogen Toxoplasma gondii , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[56]  Attila Tárnok,et al.  Laser scanning cytometry in human brain slices , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[57]  P. Lehmann,et al.  MBP-PLP fusion protein-induced EAE in C57BL/6 mice , 2006, Journal of Neuroimmunology.

[58]  D. Kedes,et al.  KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. , 2006, The Journal of clinical investigation.

[59]  E. Check Nerve inflammation halts trial for Alzheimer's drug , 2002, Nature.

[60]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[61]  L. Steinman,et al.  The coming of age for antigen‐specific therapy of multiple sclerosis , 2006, European journal of neurology.

[62]  Walter Schubert,et al.  A three‐symbol code for organized proteomes based on cyclical imaging of protein locations , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[63]  T. Rivers,et al.  OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS , 1933, The Journal of experimental medicine.

[64]  A. Meshorer,et al.  Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide , 1971, European journal of immunology.

[65]  G. Stuart,et al.  The Neuro-Paralytic Accidents of Anti-Rabies Treatment , 1928 .

[66]  M. Krantz,et al.  Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment , 2006, European journal of neurology.

[67]  P. Y. Paterson TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.

[68]  E. Spack Antigen-specific therapies for the treatment of multiple sclerosis: a clinical trial update. , 1997, Expert opinion on investigational drugs.

[69]  D. Douek,et al.  Mice lacking αβ + T cells are resistant to the induction of experimental autoimmune encephalomyelitis , 1996, Journal of Neuroimmunology.

[70]  N. Moldovan,et al.  Quantification and functional analysis of chemotaxis by laser scanning cytometry , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[71]  D. Mitchell,et al.  Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein , 1988, Journal of Neuroimmunology.

[72]  R. Holmdahl,et al.  Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers. , 2004, International immunology.

[73]  H. Lassmann,et al.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.

[74]  R. Shapira,et al.  Biological Activity and Synthesis of an Encephalitogenic Determinant , 1971, Science.

[75]  J. Freund,et al.  Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and Mycobacteria in water-in-oil emulsion. , 1947, Journal of immunology.

[76]  H. Lassmann,et al.  T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system , 1993, European journal of immunology.

[77]  N. Shen,et al.  Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different , 1989, The Journal of experimental medicine.

[78]  S. C. Elgin,et al.  Limited heterogeneity of the major nonhistone chromosomal proteins. , 1970, Biochemistry.

[79]  A. Evans,et al.  Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial , 2000, Nature Medicine.

[80]  H. L. Mason,et al.  Relationship of Homologous Brain Proteolipid to Allergic Encephalomyelitis in Guinea Pigs , 1953, Neurology.

[81]  P. Carnegie,et al.  Amino acid sequence of the encephalitogenic basic protein from human myelin. , 1971, The Biochemical journal.

[82]  S. Pervaiz,et al.  Simultaneous analysis of steady‐state intracellular pH and cell morphology by automated laser scanning cytometry , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[83]  F. Sánchez‐Madrid,et al.  Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. , 1992, Nature.

[84]  Roland Martin,et al.  Copolymer-1-induced inhibition of antigen-specific T cell activation: interference with antigen presentation , 1992, Journal of Neuroimmunology.

[85]  T. Rivers,et al.  ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS , 1935, The Journal of experimental medicine.

[86]  M. Harnett,et al.  Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES‐62 in vivo , 2003, Immunology.

[87]  J. Antel,et al.  NBI‐5788, an altered MBP83‐99 peptide, induces a T‐helper 2–like immune response in multiple sclerosis patients , 2000, Annals of neurology.

[88]  J. Rothbard,et al.  Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Rena Li,et al.  Microglia and inflammatory mechanisms in the clearance of amyloid β peptide , 2002 .

[90]  R. Knobler,et al.  Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone. , 1987, Clinical immunology and immunopathology.

[91]  S. Wassertheil-Smoller,et al.  A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. , 1987, The New England journal of medicine.

[92]  M M LIPTON,et al.  Encephalomyelitis in the Rat Following Intracutaneous Injection of Central Nervous System Tissue with Adjuvant , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[93]  J. Innes,et al.  Experimental "allergic" encephalitis: attempts to produce the disease in sheep and goats. , 1951, Journal of comparative pathology.

[94]  I. M. Morgan ALLERGIC ENCEPHALOMYELITIS IN MONKEYS IN RESPONSE TO INJECTION OF NORMAL MONKEY NERVOUS TISSUE , 1946, The Journal of experimental medicine.

[95]  R. Gold,et al.  Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes , 2006, European journal of immunology.

[96]  H. Mcdevitt,et al.  Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis [published erratum appears in J Exp Med 1988 Jul 1;168(1):455] , 1988, The Journal of experimental medicine.

[97]  C. Lumsden EXPERIMENTAL “ALLERGIC” ENCEPHALOMYELITIS II.–ON THE NATURE OF THE ENCEPHALITOGENIC AGENT , 1949 .

[98]  F. Barkhof,et al.  Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 , 1996, Neurology.

[99]  J. W. Rose,et al.  Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis , 1995, Neurology.

[100]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[101]  Hong Jiang,et al.  Role of CD8+ T Cells in Murine Experimental Allergic Encephalomyelitis , 1992, Science.

[102]  E. Heber-Katz,et al.  The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.

[103]  J. Frank,et al.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.

[104]  Lawrence Steinman,et al.  T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.

[105]  O. Majdic,et al.  Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. , 1994, Journal of immunology.

[106]  R. Ferrante,et al.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease. , 1994, The Journal of clinical investigation.

[107]  V. Lennon,et al.  Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin. , 1970, Journal of immunology.

[108]  Michael Sela,et al.  Therapeutic vaccines in autoimmunity , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[109]  J. Freund,et al.  The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis. , 1953, Journal of immunology.

[110]  J. Freund,et al.  Sensitization to Horse Serum by Means of Adjuvants , 1942 .

[111]  Lawrence Steinman,et al.  How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis , 2006, Annals of neurology.

[112]  G. Comi,et al.  Vaccination with amyloid-b peptide induces autoimmune encephalomyelitis in C 57 / BL 6 mice , 2022 .